crux
current
rnabas
therapeut
reli
associ
synthet
nucleic
acid
cellular
rna
target
antisens
oligonucleotid
bind
matur
microrna
splice
junction
premrna
repres
method
gene
therapi
respect
inhibit
micrornamedi
gene
regul
induc
altern
splice
develop
biodegrad
polym
nanoparticl
coat
cellpenetr
peptid
effect
deliv
chemicallymodifi
oligonucleotid
analog
achiev
form
gene
regul
found
nanoparticl
system
could
block
activ
oncogen
microrna
well
modul
splice
attenu
express
protooncogen
regul
gene
human
cancer
cell
reduc
cell
viabil
produc
proapoptot
effect
find
establish
polym
nanoparticl
deliveri
vector
nonconvent
form
gene
therapi
activ
cellular
deliveri
rnatarget
molecul
strong
therapeut
implic
antisens
oligonucleotid
design
inhibit
microrna
mirna
alter
splice
efficaci
increas
conjug
cellpenetr
peptid
cpp
well
variou
chemic
modif
oligonucleotid
deliveri
also
improv
encapsul
nanoscal
vehicl
offer
variou
benefit
includ
enhanc
stabil
high
load
densiti
favor
pharmacokinet
previous
develop
poli
lacticcoglycol
acid
plga
polym
nanoparticl
np
system
effect
transport
small
rna
cell
tissu
oligonucleotidecpp
conjug
cpp
attach
np
improv
deliveri
show
np
modifi
cpp
nonaarginin
arg
effect
deliv
chemicallymodifi
oligonucleotid
analog
cancer
cell
achiev
therapeut
mirna
inhibit
altern
splice
phosphorodiamid
morpholino
oligom
pmo
peptid
nucleic
acid
pna
nucleic
acid
analog
exhibit
excel
stabil
enhanc
bind
affin
target
nucleic
acid
compar
convent
dnaor
rnabas
antisens
oligonucleotid
past
decad
microrna
emerg
potent
therapeut
target
due
regul
numer
biolog
process
particularli
relat
diseas
cancer
bind
complementari
microrna
mirna
antimir
oligonucleotid
analog
pmo
pna
suppress
mirna
activ
thu
desuppress
mirnabas
downregul
gene
express
figur
addit
pmo
pna
modul
splice
premrna
bind
acceptor
donor
splice
site
flank
exon
spliceshift
oligonucleotid
mask
exon
splice
machineri
yield
variant
isoform
figur
mirna
mani
diseas
includ
cancer
link
aberr
splice
presenc
unwant
gene
isoform
studi
investig
inhibit
specif
mirna
one
first
identifi
mirna
oncogen
well
spliceshift
member
famili
antiapoptot
proapoptot
isoform
prior
studi
describ
encapsul
either
pmo
pna
nanoscal
deliveri
system
previous
pmo
conjug
proteinand
dendrimerbas
nanovehicl
system
shown
success
deliveri
antisens
agent
vivo
howev
hypothes
load
high
densiti
freeli
distribut
pmo
np
may
improv
deliveri
efficaci
previous
shown
np
deliv
pna
associ
dna
order
direct
sitespecif
genom
recombin
howev
dna
compon
requir
addit
polyc
counterion
spermidin
effici
load
like
nucleic
acid
deliveri
vehicl
np
compris
cation
compon
facilit
associ
anion
dna
rna
howev
polyc
may
deleteri
return
exampl
insid
cell
electrostat
complex
must
dissoci
releas
bioactiv
nucleic
acid
cation
agent
may
nonspecif
interact
offtarget
cellular
compon
molecul
becom
heavili
proton
may
induc
cellular
toxic
osmot
swell
intracellular
vesicl
cation
compon
essenti
np
format
base
emulsiondriven
process
therefor
hypothes
np
devoid
cation
addit
could
load
high
densiti
chargeneutr
oligonucleotid
analog
unlik
nucleic
acid
backbon
pmo
pna
neutral
charg
densiti
therefor
load
pmo
pna
np
present
platform
deliveri
antisensebas
gene
therapi
reli
electrostat
interact
np
fabric
use
doubl
emuls
solvent
evapor
method
plga
durect
corpor
pelham
al
usa
termin
ester
group
monom
ratio
dlg
inher
viscos
dissolv
methylen
chlorid
nucleic
acid
pmo
pna
ssdna
suspend
water
ad
polym
mixtur
ratio
nmole
nucleic
acid
per
mg
polym
note
spliceshift
nucleic
acid
coload
np
ratio
nmolemg
sonic
primari
emuls
ad
secondari
aqueou
solut
wv
polyvinyl
alcohol
pva
sonic
secondari
emuls
ad
solut
wv
pva
incub
hour
allow
methylen
chlorid
evapor
np
harden
np
wash
lyophil
cryoprotect
trehalos
equal
mass
ratio
polym
carbohydr
np
load
ssdna
cation
counterion
prior
np
synthesi
spermidin
sigmaaldrich
st
loui
mo
usa
complex
ssdna
ntop
ratio
np
surfac
modifi
previous
describ
except
arg
keck
peptid
synthesi
facil
yale
univers
new
ct
usa
use
cpp
sequenc
rrrrrrrrrggc
pmo
gene
tool
llc
philomath
usa
pna
biosynthesi
inc
lewisvil
tx
usa
ssdna
keck
oligonucleotid
synthesi
facil
yale
univers
new
ct
usa
synthes
use
follow
sequenc
quantif
studi
fluorescein
rhodamin
conjug
end
nucleic
acid
load
measur
spectrofluoresc
np
hydrolyz
naoh
dissolv
dmso
control
releas
measur
quantifi
releas
fluoresceinlabel
pna
pmo
ssdna
variou
time
point
np
suspend
ml
phosphat
buffer
salin
pb
ph
incub
gentl
shake
time
point
hr
np
pellet
centrifug
rcf
min
ml
supernat
collect
analyz
spectrofluoresc
excit
nm
emiss
nm
use
spectramax
molecular
devic
sunnyval
ca
usa
np
resuspend
addit
ml
fresh
pb
use
serial
control
releas
analysi
np
size
surfac
charg
measur
use
zetas
nano
zs
malvern
instrument
inc
westborough
usa
analysi
conduct
use
np
mgml
suspend
distil
water
ph
room
temperatur
intern
cppmodifi
np
monitor
use
flow
cytometri
cell
incub
coumarin
np
np
cell
ratio
incub
min
cell
wash
pb
harvest
use
cell
dissoci
buffer
invitrogen
carlsbad
ca
usa
intern
np
enrich
incub
cell
wv
trypan
blue
min
quench
extracellular
fluoresc
live
cell
ie
surfaceassoci
np
cell
wash
bsa
pb
analyz
facscan
bd
bioscienc
san
jose
ca
usa
cell
cultur
experi
kb
cell
atcc
manassa
va
usa
maintain
folatefre
medium
invitrogen
contain
vv
fetal
bovin
serum
fb
atlanta
biolog
lawrencevil
ga
usa
sem
np
sputterco
thin
layer
gold
visual
use
esemfeg
sem
fei
hillsboro
usa
size
distribut
measur
micrograph
analysi
least
np
use
imag
analysi
softwar
imagej
nation
institut
health
tem
np
load
ww
oso
synthesi
incub
cell
overnight
cell
wash
fix
glutaraldehyd
dehydr
embed
resin
section
nmthick
cut
mount
onto
glowdischarg
carbonco
formvar
grid
stain
uranyl
acet
lead
citrat
standard
method
sampl
view
use
tecnai
biotwin
tem
fei
confoc
imag
argnp
load
fitclabel
pmo
incub
overnight
cell
grown
chamber
coverglass
rochest
ny
usa
np
cell
ratio
cell
wash
fb
vv
pb
fix
paraformaldehyd
permeabil
use
triton
pb
per
manufactur
instruct
actin
stain
texa
phalloidin
invitrogen
nuclei
stain
hoescht
invitrogen
cell
mount
slow
fade
gold
invitrogen
visual
use
tc
spectral
confoc
microscop
leica
bannockburn
il
usa
antisens
luciferas
experi
np
contain
antiluc
anticrl
oligonucleotid
analog
incub
ml
pb
mgml
indic
time
np
pellet
centrifug
rcf
min
entir
volum
pb
remov
replac
fresh
buffer
sampl
contain
releas
oligonucleotid
analog
concentr
vacuum
resuspend
h
aliquot
ad
quick
coupl
transcriptiontransl
system
promega
madison
wi
usa
luciferas
activ
measur
use
manufactur
protocol
dualluciferas
report
experi
mirna
sensor
gener
insert
target
sequenc
renilla
luciferas
vector
promega
cell
transfect
report
use
lipofectamin
invitrogen
use
manufactur
protocol
hour
cell
treat
argnp
contain
antimir
relev
control
concentr
cell
lysat
measur
luciferas
activ
hour
initi
transfect
use
dualluciferas
report
assay
system
promega
cell
incub
argnp
contain
relev
control
concentr
hour
total
rna
extract
use
trizol
invitrogen
accord
standard
procedur
dna
digest
qiagen
valencia
ca
usa
rna
isol
repeat
trizol
extract
rt
qpcr
perform
use
microrna
system
appli
biosystem
foster
citi
ca
usa
myiq
realtim
thermal
cycler
biorad
hercul
ca
usa
level
normal
intern
control
ambion
austin
tx
usa
cell
incub
argnp
contain
spliceshift
pmo
bind
donor
splice
site
flank
exon
relev
control
total
pmo
concentr
endoport
group
cell
incub
spliceshift
pmo
well
endoport
hour
total
rna
extract
earlier
describ
rt
perform
use
iscript
cdna
synthesi
kit
biorad
pcr
perform
use
titanium
taq
dna
polymeras
clontech
mountain
view
ca
usa
pcr
product
analyz
agaros
gel
electrophoresi
visual
safe
invitrogen
follow
primer
use
fwd
dose
respons
experi
cell
incub
variou
argnp
formul
indic
pmo
concentr
hour
note
due
coload
spliceshift
pmo
mcll
total
nucleic
acid
concentr
indic
amount
dose
respons
apoptosi
studi
promega
use
assay
cell
viabil
apoptot
dna
fragment
analysi
cell
incub
indic
pmo
argnp
hour
cell
death
elisa
kit
roch
appli
scienc
use
determin
amount
apoptot
dna
fragment
dna
fragment
index
determin
quantifi
cytosol
histoneassoci
monoand
oligonucleosom
applic
either
student
ttest
anova
use
determin
statist
signific
unless
otherwis
note
data
report
averag
standard
deviat
repres
independ
experi
np
size
rang
nm
tabl
coat
argininerich
cpp
arg
figur
bca
assay
thermo
fisher
scientif
inc
rockford
il
usa
measur
surfac
densiti
ug
peptidemg
np
correspond
arg
molecul
per
npthe
number
np
given
mass
calcul
use
plga
np
densiti
gcm
assum
spheric
volum
np
flow
cytometri
fluoresc
label
np
reveal
impact
surfac
modif
np
coat
arg
argnp
demonstr
greater
associ
human
kb
oral
carcinoma
cell
unmodifi
np
np
coat
cpp
tat
antp
figur
transmiss
electron
microscopi
tem
confirm
argnp
local
cytosol
figur
np
character
abil
encapsul
chargeneutr
pna
pmo
load
densiti
pmole
pnamg
np
pmole
pmomg
np
achiev
tabl
degre
encapsul
substanti
greater
observ
np
load
either
singlestrand
dna
ssdna
pmole
dnamg
np
ssdna
complex
cation
counterion
spermidin
ssdna
cation
pmole
dnamg
np
coat
np
arg
add
cation
compon
surfac
nanoparticl
howev
charg
surfac
ligand
appear
impact
load
nucleic
acid
argnp
synthesi
arg
ad
nanoparticl
surfac
nucleic
acid
emulsifi
nascent
nanoparticl
phase
note
cargo
surfacemodifi
argnp
similar
load
valu
compar
uncoat
np
argnp
encapsul
pna
pmo
ssdna
ssdna
cation
load
pmolesmg
np
respect
np
surfac
charg
depend
charg
encapsul
agent
tabl
np
load
chargeneutr
pmo
pna
valu
respect
valu
similar
plga
np
encapsul
agent
np
load
ssdna
ssdna
cation
valu
respect
valu
influenc
presenc
charg
compon
control
releas
pna
pmo
occur
initi
burst
first
hour
follow
sustain
releas
day
week
one
week
either
encapsul
pna
pmo
releas
np
figur
free
dna
dna
complex
cation
counter
ion
also
biphas
sustain
releas
profil
due
lower
load
densiti
net
amount
dna
releas
per
np
much
less
chargeneutr
oligonucleotid
analog
figur
note
coat
np
surfac
ligand
high
cation
charg
densiti
ie
cpp
may
alter
releas
dynam
encapsul
anion
nucleic
acid
howev
chargeneutr
oligonucleotid
analog
avoid
electrostat
interact
freeli
diffus
nanoparticl
howev
encapsul
nucleic
acid
cargo
releas
profil
uncoat
np
argnp
data
shown
significantli
differ
base
arg
coat
densiti
np
surfac
area
less
np
surfac
cover
ligand
therefor
densiti
even
charg
molecul
releas
nucleic
acid
cargo
significantli
occlud
electrostat
interact
demonstr
util
control
releas
system
deliv
bioactiv
chargeneutr
nucleic
acid
np
load
antisens
pmo
bind
luciferas
mrna
inhibit
translat
span
one
week
total
amount
releas
pmo
collect
variou
time
interv
sampl
ad
cellfre
coupl
vitro
transcriptiontransl
mixtur
promega
madison
wi
usa
inhibit
translat
luciferas
figur
sampl
first
hour
subsequ
hour
produc
inhibit
luciferas
activ
express
sampl
next
hour
achiev
less
inhibit
aforement
burst
releas
phase
sampl
probabl
due
slower
pmo
releas
rate
result
fewer
pmo
molecul
collect
sampl
supernat
collect
period
incub
np
addit
five
day
result
sustain
releas
enough
pmo
achiev
inhibit
basi
enhanc
cellular
uptak
cytosol
local
high
load
densiti
favor
releas
rate
postul
argnp
load
chargeneutr
antimir
could
effect
inhibit
mirna
specif
monitor
inhibit
use
dual
luciferas
report
system
target
bind
sequenc
insert
renilla
luciferas
firefli
luciferas
use
normal
endogen
repress
renilla
luciferas
express
derepress
presenc
kb
cell
transfect
sensor
exhibit
increas
normal
renilla
luciferas
activ
expos
argnp
deliv
figur
accord
attenu
function
detect
level
kb
cell
decreas
respons
deliv
argnp
figur
importantli
argnp
decreas
level
np
surfac
modif
decreas
level
rel
untreat
cell
cell
treat
argnp
load
scrambl
control
pmo
antimir
crl
show
loss
emphas
specif
mirnabas
therapeut
strategi
interestingli
despit
greater
rna
bind
affin
pna
compar
pmo
pna
pmo
function
compar
antmir
therefor
rest
studi
focus
nanoparticulatebas
deliveri
pmo
gene
therapi
typic
involv
either
increas
eg
dna
deliveri
downregul
eg
rna
interfer
level
specif
gene
modul
splice
pattern
present
multimod
form
gene
regul
accomplish
process
oligonucleotid
mask
exon
simultan
reduc
product
specif
gene
isoform
induc
splice
subsequ
transcript
anoth
isoform
uniqu
properti
chargeneutr
oligonucleotid
analog
abil
passiv
diffus
nucleu
siteofact
altern
splice
therefor
postul
argnp
could
effect
transport
chargeneutr
pmo
cell
cytosol
figur
subsequ
releas
pmo
could
transloc
nucleu
induc
altern
splice
observ
fitclabel
pmo
deliv
argnp
abl
enter
nucleu
kb
cell
figur
exclud
possibl
argnp
direct
role
facilit
nuclear
transport
pmo
howev
like
sustain
releas
pmo
argnp
gener
diffus
gradient
nucleu
nucleu
spliceblock
oligonucleotid
free
bind
premrna
alter
splice
gene
interest
altern
splice
model
two
isoform
differ
size
function
figur
antiapoptot
bp
proapoptot
bp
kb
cell
argnp
deliv
pmo
mask
exon
premrna
manipul
splice
machineri
predominantli
produc
isoform
oppos
isoform
figur
figur
note
pmo
pna
requir
deliveri
vector
eg
nanoparticl
endoport
order
effici
enter
cell
endoport
function
promot
nonspecif
uptak
extracellular
milieu
key
differ
argnp
applic
therapeut
deliveri
system
chose
investig
gene
therapi
target
due
function
relev
cell
mainten
observ
kb
cell
sensit
argnp
deliv
nm
spliceswitch
pmo
nm
figur
deliveri
scrambl
control
pmo
anticrl
use
argnp
well
empti
argnp
encapsul
agent
show
signific
cytotox
figur
mechanist
therapeut
strategi
promot
apoptot
signal
dna
fragment
enrich
cytoplasm
hallmark
apoptosi
accord
vari
cytotox
respons
extent
cytosol
dna
fragment
cell
treat
splice
switch
pmo
greater
untreat
cell
respect
figur
effect
gene
therapi
deliveri
vehicl
must
abl
travers
cell
membran
transport
payload
cytosol
previous
demonstr
np
capit
membran
transduct
properti
surfaceattach
cpp
whether
direct
membran
transloc
endocytosi
combin
entir
differ
mechan
arg
enter
cell
ultim
reach
cytoplasm
process
like
confound
tether
polym
nanoparticl
peptid
howev
argnp
observ
freeli
distribut
cytosol
figur
note
seemingli
greater
degre
argnp
uptak
cell
visual
confoc
microscopi
figur
compar
tem
figur
result
larger
field
view
thicker
imag
section
confoc
imagingth
tem
slice
thick
nm
confoc
imag
plane
zheight
base
imag
estim
intracellular
densiti
argnp
npum
estim
fig
npum
estim
fig
escap
endolysosom
degrad
vesicular
sequestr
paramount
nucleic
acid
intend
bind
mirna
cytosol
premrna
nucleu
form
gene
therapi
induc
pmo
pna
due
chargeneutr
backbon
nucleic
acid
analog
effect
util
convent
oligonucleotid
deliveri
system
reli
electrostat
interact
fabric
plga
np
reli
hydrophob
effect
instead
charg
interact
due
chargeneutr
backbon
pmo
pna
demonstr
higher
load
np
compar
anion
nucleic
acid
tabl
addit
pna
pmo
compar
high
encapsul
densiti
attribut
similar
chemic
composit
physic
properti
np
form
use
doubl
emuls
solvent
evapor
process
therefor
denser
load
chargeneutr
oligonucleotid
analog
like
due
lack
intermolecular
electrostat
repuls
promot
outward
diffus
nucleic
acid
np
fabric
furthermor
plga
np
widespread
applic
deliveri
platform
function
reservoir
control
releas
encapsul
drug
agent
entrap
plga
np
gradual
releas
diffus
hydrolysi
polym
matrix
although
releas
pmo
pna
ssdna
follow
similar
kinet
figur
greater
load
densiti
pmo
pna
make
potenti
effect
agent
npmediat
gene
therapi
recent
year
inhibit
mirna
antimir
molecul
alter
splice
spliceshift
oligonucleotid
emerg
promis
therapeut
strategi
nonetheless
current
strategi
deliveri
agent
induc
form
gene
therapi
shown
promis
vivo
effect
deliveri
strategi
involv
administr
free
chemicallymodifi
antisens
molecul
encapsul
high
densiti
agent
plga
np
may
provid
dose
advantag
use
deliveri
system
histori
vivo
success
observ
load
amount
pna
pmo
np
therapeut
relev
particularli
antimirbas
approach
calcul
singl
np
contain
antimir
molecul
cancer
connect
mirna
oncogen
typic
copi
aberrantli
express
mirna
per
cell
therefor
deliveri
nanoparticl
per
cancer
cell
would
suffici
match
antimir
dose
target
mirna
level
similar
calcul
less
predict
target
premrna
sinc
singl
altern
splice
mrna
translat
produc
numer
copi
protein
argnp
effect
deliv
pmo
exploit
inhibit
alter
splice
therapeut
purpos
therapi
efficaci
dispar
like
due
rel
site
action
argnp
effici
deliv
pmo
siteofact
mirna
block
cytosol
altern
splice
cytosol
nucleu
addit
inhibit
spliceshift
induc
apoptosi
via
differ
biolog
pathway
downregul
multitud
cellular
target
directli
promot
apoptosi
includ
well
ancillari
antisurviv
target
contrast
apoptot
role
defin
involv
apoptosi
regul
protein
therefor
inhibit
may
induc
varieti
cellular
respons
spliceshift
proapoptot
isoform
definedyet
possibl
less
potentoutcom
studi
present
deliveri
technolog
inhibit
mirna
alter
splice
gene
therapi
deliveri
vehicl
np
sever
key
advantag
np
provid
safe
biodegrad
matrix
protect
encapsul
nucleic
acid
np
coat
surfac
ligand
eg
arg
enhanc
cellular
uptak
impart
function
np
deliv
high
dose
chargeneutr
oligonucleotid
analog
sustain
period
time
np
also
effect
vivo
deliveri
relat
studi
develop
np
inhibit
oncogen
mirna
aggress
lymphoma
tumor
model
babar
cheng
et
al
unpublish
result
regul
mirna
activ
alter
splice
rel
nascent
therapeut
strategi
envis
nanoparticul
deliveri
system
advanc
widespread
use
form
gene
therapi
workflow
schemat
altern
splice
mirna
inhibit
induc
nonaarginineco
nanoparticl
argnp
deliv
chargeneutr
oligonucleotid
analog
argnp
compris
spheric
plga
core
coat
pegyl
arg
dehydr
argnp
visual
scan
electron
microscopi
sem
intracellular
uptak
osmium
tetroxideload
argnp
visual
transmiss
electron
microscopi
tem
scale
bar
sem
tem
micrograph
repres
comparison
coumarin
np
coat
antp
arg
tat
unmodifi
np
pegyl
np
use
control
cpp
densiti
ug
peptid
per
mg
np
surfac
np
increas
lefttoright
individu
group
cellular
associ
intern
monitor
use
flow
cytometri
trypan
blue
quench
extracellular
fluoresc
shown
mean
channel
fluoresc
statist
analysi
perform
respect
unmodifi
nanoparticl
either
associ
intern
group
p
p
p
surfac
charg
load
properti
np
encapsul
nucleic
acid
